Metabolism Study Notes: Disorders of the Pancreas, Liver, and Purine Metabolism

THE PANCREAS: ANATOMY AND PHYSIOLOGY

• Dual-Function Gland: The pancreas serves both endocrine and exocrine roles within the body.     * Exocrine Function: It produces and releases digestive enzymes (trypsin, lipase, and amylase) through a duct system into the small intestine. These enzymes are responsible for the breakdown of fats, proteins, and carbohydrates.     * Endocrine Function: It secretes hormones, specifically insulin and glucagon, directly into the bloodstream to regulate blood glucose levels.
• Anatomy and Location:     * Situated behind the stomach.     * Dimensions: Approximately $6-10\,\text{inches}$ long.     * Structural Components: Comprised of four distinct parts: the head, neck, body, and tail.

PANCREATITIS: PATHOPHYSIOLOGY AND TYPES

• Definition: An inflammatory disorder categorized by high levels of inflammation.
• Mechanisms of Injury: Damage occurs via autodigestion, where the pancreas's own enzymes (trypsin, lipase, and amylase) begin to digest the organ itself. This typically results from a reflux of bile from the liver and contents of the duodenum into the pancreatic duct.
• Pathological Progression: Inflammation and swelling lead to structural impairment or ductal blockage. This decreases the secretion of bicarbonate, subsequently increasing the acidity of stomach contents.
• Comparison of Types:     * Acute Pancreatitis: A sudden inflammation that can range from mild to severe/fatal. Normal function can potentially return within $6\,\text{months}$.     * Chronic Pancreatitis: Characterized by prolonged, progressive inflammation resulting in the gradual destruction of pancreatic tissue. This leads to a partial or complete loss of both endocrine and exocrine functions. It is often a result of alcohol consumption, heredity, hyperparathyroidism, hypertriglyceridemia, autoimmune disorders, or trauma.

ACUTE PANCREATITIS: CLINICAL PRESENTATION AND DIAGNOSIS

• Symptoms:     * Intractable abdominal pain that is often mid-abdominal but may radiate to the upper abdomen, sides, and back.     * Nausea, vomiting, and flatulence, typically occurring after eating.     * Steatorrhea: Stools that are frothy and foul-smelling due to impaired fat digestion.     * Relieving Factors: Pain may be reduced by sitting upright or assuming a fetal position.
• Clinical Signs:     * Jaundice, diminished bowel sounds, abdominal distention, and tenderness.     * Vitally unstable: Hypotension (due to hypovolemia), fever, tachycardia, and shallow breathing.     * Metabolic findings: Hyperglycemia.     * Physical markings: Peri-umbilical or flank bruising.
• Diagnostic Laboratory Findings:     * Elevated serum amylase and lipase.     * Elevated liver enzymes and bilirubin (particularly if gallstones are the cause).     * Elevated White Blood Cell (WBC) count and blood sugar.     * Stool analysis: High fat content.     * Decreased electrolytes: Serum Calcium ($Ca^{2+}$), Potassium ($K^+$), and Magnesium ($Mg^{2+}+$).
• Imaging Diagnostics:     * CT Scan: Reveals edema and pancreatic necrosis.     * Abdominal Ultrasound: Detects pancreatic inflammation.     * MRI: Identifies abnormalities of the gallbladder, pancreas, and associated ducts.

SPECIAL CLINICAL SIGNS: GREY-TURNER’S AND CULLEN’S

• Grey-Turner’s Sign: Discoloration of the flanks appearing like bruising; indicates catastrophic abdominal concerns.
• Cullen’s Sign: Bluish discoloration around the umbilicus; also indicates catastrophic abdominal concerns.
• Clinical Significance: Both signs are associated with severe acute pancreatitis due to the leakage of hemorrhagic fluid from the pancreas.
• Acute Management: Requires intravenous (IV) fluids with electrolytes and continuous monitoring of vital signs.

PANCREATIC CANCER AND DIABETES

• Pancreatic Cancer: A malignancy accounting for $3\%$ of all cancers.     * Locations: Can occur in the head, body, or tail. Primary or metastatic.     * Key Indicator: Tumors in the head of the pancreas often cause jaundice and are detected earlier, though they remain highly lethal.
• Diabetes: Pancreatic disorders often lead to decreased insulin production or the inability to utilize insulin properly.

MEDICAL AND SURGICAL MANAGEMENT OF PANCREATITIS

• Therapeutic Focus: Relieving pain, reducing pancreatic secretions, restoring fluid/electrolyte balance, and preventing complications (sepsis, shock, ARDS, peritonitis).
• Initial Interventions:     * NPO Status: The patient is kept "nothing by mouth" to rest the pancreas.     * Nasogastric (NG) Tube: Suctioning reduces nausea, vomiting, and distention.     * Hydration: IV fluids and albumin to treat fluid trapped in the peritoneum.
• Nutritional Support: Total Parenteral Nutrition (TPN) may be ordered to reduce metabolic stress.
• Pharmacology:     * Pain: Opioids like Morphine or Hydromorphone (Dilaudid). Note: Meperidine (Demerol) is contraindicated as it can worsen pancreatitis.     * Acid Suppression: H2 blockers (famotidine) or Proton Pump Inhibitors (PPIs like omeprazole).     * Antibiotics: Used for the prevention of abscesses or cysts.

ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP)

• Procedure description: Combines endoscopy with x-ray to visualize pancreatic and bile ducts.
• Process: Scope enters through the mouth and esophagus into the duodenum. A flexible tube is passed through the scope into the ducts to inject contrast dye.
• Objectives: Identification of blockages, stones, tumors, or abnormalities; enables the placement of stents.

CHRONIC PANCREATITIS: CHARACTERISTICS AND SURGICAL OPTIONS

• Clinical Presentation: Severe persistent pain, weight loss despite no eating habit changes, steatorrhea, dark colored urine, edema (loss of plasma protein), and ascites.
• Pancreatogenic Diabetes: High blood sugars resulting from pancreatic damage.
• Non-Surgical Management: Abstinence from alcohol, low-fat diet, and correction of co-morbidities like gallbladder disease.
• Pancreatic Enzyme Product (PEP): Supplements containing amylase, lipase, protease, and pancrelipase must be FDA approved.
• Surgical Interventions:     * The Whipple Procedure: Resection of the pancreatic head, duodenum, gallbladder, and bile duct.     * The Beger Resection: Removes the pancreatic head but preserves the duodenum.     * Total Pancreatectomy: Removal of the entire organ for unresponsive pain or cancer prevention.

NURSING MANAGEMENT AND TEACHING FOR PANCREATITIS

• Monitoring: Pain, hypovolemia, respiratory status (decreased effort due to pain), lung sounds, bowel sounds, I&O, nutritional status, electrolytes, and glucose.
• Inpatient Dietary Progression: NPO/NG tube → Clear liquids → Soft bland foods → Enteral nutrition (if oral is not tolerated).
• Chronic Diet: Low fat, high protein, high carbohydrate diet; supplements of Vitamin C and B complex.
• Patient Education:     * Four or more small meals ("grazing").     * Take pancreatic enzymes before meals/snacks.     * Total abstinence from alcohol (referral to 12-step programs if needed).     * Smoking cessation.

THE LIVER: ANATOMY AND FUNCTIONS

• Anatomy: Consists of four lobes.     * Hepatic Artery: Supplies high-oxygen blood.     * Portal Vein: Transports nutrient-rich, low-oxygen blood from the intestinal tract.     * Hepatic Veins: Returns blood to the vena cava.
• Metabolic Functions:     * Glucose Regulation: Converts glucose to glycogen for storage in the liver and muscles.     * Protein/Fat Metabolism: Metabolizes drugs, chemicals, and bacteria.     * Urea Cycle: Converts ammonia (nitrogenous waste) into urea for excretion.     * Bile Production: Forms bile for the emulsification and digestion of fats, released through the sphincter of Oddi.     * Coagulation: Produces factors such as prothrombin and fibrinogen.

BILIRUBIN AND JAUNDICE

• Bilirubin Lifecycle: A byproduct of RBC breakdown ($120\,\text{day}$ cycle).     * Globin: Broken into amino acids for reuse.     * Heme: Converted to bilirubin, binds to albumin, and transported to the liver.     * Excretion: Liver makes it water-soluble; excreted in urine (yellow color) and feces (brown color).
• Jaundice (Icterus): Visible discoloration of skin/sclera at blood levels exceeding $2.5\,mg/dL$. Normal levels range from $0.2-1.3\,mg/dL$.

TYPES OF JAUNDICE

• Hemolytic Jaundice: Overproduction of bilirubin from RBC destruction (e.g., sickle cell anemia, transfusion reactions). High unconjugated (indirect) levels.
• Hepatocellular Jaundice: Liver cannot clear normal bilirubin (e.g., hepatitis, chemical toxicity). High conjugated and unconjugated levels.
• Obstructive Jaundice: Blockage in the bile duct (e.g., gallstones, tumors). High conjugated (direct) levels.
• Diagnostic Formula: Total Bilirubin - Direct Bilirubin = Indirect (Unconjugated) Bilirubin.
• HOT Liver Mnemonic:     * H: Hemolysis.     * O: Obstruction.     * T: Tumor.     * Liver Disease: Hepatitis.

NEONATAL JAUNDICE

• Physiologic Jaundice: Normal transient condition; appears after the first $24\,\text{hours}$, peaks at days $2-4$. Resolve within $7-10\,\text{days}$. Indirect levels of $5-12\,mg/dL$ are common.
• Pathologic Jaundice: Abnormal; appears within the first $24\,\text{hours}$. Total bilirubin $>15-17\,mg/dL$ is concerning.     * Kernicterus: Brain damage/neurotoxicity resulting from untreated pathologic jaundice.     * Treatment: Phototherapy and exchange transfusion.

CIRRHOSIS AND PORTAL HYPERTENSION

• Definition: Chronic degenerative, irreversible liver disorder characterized by scarred tissue.
• Stages calculation: Based on bilirubin, albumin, ammonia, ascites, neurological status, and nutrition.
• Portal Hypertension: Abnormally high pressure in the portal vein, leading to:     * Esophageal Varices: Enlarged/weakened veins that may rupture. Symptoms include hematemesis and melena.     * Ascites: Accumulation of fluid in the abdomen.     * Hepatic Encephalopathy: Toxins (ammonia) affecting the brain, causing tremors and mental disturbances.     * Hepatorenal Syndrome: Kidney failure caused by reduced blood flow from liver disease.
• Comparison of Manifestations:     * Compensated: Early stage; often asymptomatic but may show vascular spiders, reddened palms (palmar erythema), and ankle edema. Median survival is $12\,\text{years}$.     * Decompensated: Advanced stage; includes jaundice, ascites, muscle wasting, clubbing of fingers, and spontaneous bruising.

CLINICAL STAGES OF ENCEPHALOPATHY

• Prodromal: Slurred speech, vacant stare, restlessness.
• Impending: Asterixis (flapping tremors), apraxia, lethargy.
• Stuporous: Marked mental confusion, somnolence.
• Coma: Unarousable, seizures, Fetor Hepaticus ("breath of the dead"), and death.

MEDICAL AND NURSING MANAGEMENT OF CIRRHOSIS

• Goal: Preservation of remaining liver function; no known cure.
• Pharmacology:     * Lactulose: Given to detoxify ammonia and draw water into the bowel (causes diarrhea).     * Spironolactone (Aldactone): Potassium-sparing diuretic for ascites.     * Cholestyramine (Questran): Binds bile salts to reduce itching (pruritus).     * Vitamins: Vitamin K for clotting; B1, B complex, A, C, folic acid, thiamine.
• Diagnostic Interventions: Liver biopsy (Gold Standard using fluoroscopy), EGD (screening for varices), and Paracentesis (draining fluid).
• Nursing Duties: Abdominal girth measurements, daily weights, monitoring PT/INR, ammonia, and liver enzymes.
• Diet: Reduced sodium, fluid restriction, high calorie, low protein ($20-40\,gm$), and low fat.

LIVER FAILURE AND CANCER

• Liver Failure: Occurs when toxins build up due to cellular death. Mortality is highly influenced by gender (male) and ethnicity (Native American highest). Acute liver failure accounts for $50-75\%$ of such deaths.
• Liver Cancer:     * Primary (HCC): Rare; associated with Hep B/C and MASH (formerly NASH/NAFLD).     * Metastatic: Most common; spreads from breast, lung, or GI tract.     * Markers: Elevated Alpha-fetoprotein (AFP).     * Surgical: Lobectomy (if confined to one lobe).

VIRAL AND NON-VIRAL HEPATITIS

• Phases of Viral Hepatitis:     1. Incubation: Asymptomatic but infectious.     2. Pre-icteric/Prodromal: Flu-like symptoms, malaise, joint pain.     3. Icteric: Jaundice, itching, dark urine, light stools.     4. Post-icteric: Liver enzymes return to normal as symptoms resolve.
• Hepatitis Types:     * Hep A: Fecal-oral route; Havrix vaccine.     * Hep B: Blood/body fluids contact; linked to cancer; Recombivax vaccine.     * Hep C: Blood contact; high rate with HIV; treated with direct-acting antivirals.     * Hep D: Co-infection with Hep B.     * Hep E: Enteric (contaminated water/meat); dangerous for pregnant women.     * Hep G: Blood-borne; occurs after blood transfusion.
• Hepatotoxicity: Avoid Acetaminophen ($>3-4\,g/day$), Statins, and certain supplements like Kava, Aloe Vera, and Black Cohosh.

GOUT (GOUTY ARTHRITIS)

• Definition: Inflammatory arthritis caused by a disruption in purine metabolism, leading to uric acid crystals in joints.
• Diagnostics:     * Serum Uric Acid: $3.5–7.2\,mg/dL$.     * BUN: $6-20\,mg/dL$.     * Serum Creatinine: $0.5-1.2\,mg/dL$.     * Sed Rate: Elevated ($0-20$ is normal).
• Symptoms: Severe joint pain, red/swollen joints, and Tophi (crystal deposits under skin). Attacks last $3-14\,\text{days}$.
• Food Triggers: Red meat, organ meats, shellfish, beer, red wine, and high fructose corn syrup.
• Pharmacology:     * Acute: Colchicine (causes diarrhea; stop if it occurs), NSAIDs (Indomethacin, Ibuprofen).     * Prevention: Allopurinol/Febuxostat (watch for Stevens-Johnson rash/vision changes), Probenecid (avoid Aspirin/ASA).     * Krystexxa: IV infusion every $2\,\text{weeks}$ for unresponsive cases.